XML 34 R24.htm IDEA: XBRL DOCUMENT v3.25.3
Share-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Summary of Share-Based Compensation Expense The following table summarizes share-based compensation expense for the periods presented (in thousands):
Three Months Ended 
September 30,
Nine Months Ended 
September 30,
2025202420252024
Research and development$2,471 $5,128 $11,990 $16,217 
General and administrative4,728 5,892 16,495 19,227 
Restructuring costs (1)
— — 2,081 — 
Total share-based compensation expense$7,199 $11,020 $30,566 $35,444 
________________
(1)Restructuring costs for the nine months ended September 30, 2025 includes $2.1 million of share-based compensation expense related to the contractual acceleration of vesting of certain option awards granted to executive officers.
Fair Value of Options Granted The fair value of the options granted to employees and non-employee directors during the nine months ended September 30, 2025 and 2024 was estimated as of the grant date using the Black-Scholes option-pricing model using the key assumptions listed in the following table. There were no stock options granted during the three months ended September 30, 2025 and 2024, thus no key assumptions are shown in the table below.
Nine Months Ended 
September 30,
20252024
Expected term (in years)4.78-5.764.60-5.56
Expected volatility76.5%-79.0%74.5 %-78.6%
Risk-free interest rate3.8%-4.4%3.8 %-4.7%
Expected dividend yield—%—%
Weighted average grant date fair value$9.49$19.21
Summary of Company's Share Option Activity
The following table summarizes the Company’s stock option activity during the nine months ended September 30, 2025:
OptionsWeighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term (years)
Aggregate
Intrinsic
Value
(in thousands)
Outstanding at December 31, 2024
11,107,373 $28.70 6.16$3,401 
Granted
2,086,686 14.26 
Exercised— — 
Forfeited(1,331,514)29.02 
Expired(235,332)27.70 
Outstanding at September 30, 2025
11,627,213 $26.09 4.75$505 
Vested and expected to vest at September 30, 2025
11,259,635 $26.23 4.62$472 
Exercisable at September 30, 2025
8,902,882 $26.75 3.60$37 
Share-Based Payment Arrangement, Outstanding Award, Activity, Excluding Option
The following table summarizes the activity and related information for RSUs during the nine months ended September 30, 2025:
Number of UnitsWeighted Average
Grant-Date
Fair Value
Weighted
Average
Remaining
Contractual
Term (years)
Aggregate
Intrinsic
Value
(in thousands)
Unvested at December 31, 2024
6,000 $51.80 0.71$83 
Units Granted
1,298,136 8.65 
Units Vested(3,000)68.71 
Units Forfeited(168,385)14.95 
Unvested at September 30, 2025
1,132,751 $7.78 1.33$11,056 
Unvested and expected to vest at September 30, 2025
972,844 $7.78 1.28$9,495